News & Updates

Are fertility treatments safe in young breast cancer survivors who have high-risk genes?
Are fertility treatments safe in young breast cancer survivors who have high-risk genes?
13 Jun 2024 byAudrey Abella

In young breast cancer survivors harbouring BRCA1/2 pathogenic variants, using assisted reproductive techniques (ART) to conceive did not appear to negatively affect maternal or pregnancy outcomes, findings from an international retrospective cohort study suggest.

Are fertility treatments safe in young breast cancer survivors who have high-risk genes?
13 Jun 2024
Chemo plus immunotherapy improves survival in advanced endometrial cancer
Chemo plus immunotherapy improves survival in advanced endometrial cancer
09 Jun 2024

Adding immunotherapy to the first-line treatment for advanced and metastatic endometrial cancer may significantly improve some oncologic outcomes, particularly within the mismatch repair deficiency/microsatellite instability-hypermutated (MMRd/MSI-H) subset, suggests a study.

Chemo plus immunotherapy improves survival in advanced endometrial cancer
09 Jun 2024
Multiethnic GDM study points to unique gut microbiome profile
Multiethnic GDM study points to unique gut microbiome profile
05 Jun 2024 byJairia Dela Cruz

Women with gestational diabetes mellitus (GDM) share a common gut bacterial profile regardless of ethnic differences, according to a Singapore study, suggesting a role for specific gut bacteria in GDM pathophysiology.

Multiethnic GDM study points to unique gut microbiome profile
05 Jun 2024